Venture Kick
Venture Kick is a private philanthropic initiative based in Zurich, Switzerland, founded in 2007 to support Swiss startups at the pre-seed stage. It provides up to 150,000 Swiss francs in funding and offers structured entrepreneurial training aimed at developing sustainable businesses. Entrepreneurs participate in a competitive process, pitching their ideas up to three times for increasing funding amounts, while receiving valuable feedback from expert juries. To date, Venture Kick has supported 600 startup projects with a total of 24.9 million francs, leading to the incorporation of 454 active companies that have created over 6,000 jobs and attracted approximately 2.49 billion francs in subsequent investments. Companies founded by Venture Kick alumni have notably achieved significant recognition, with 55 percent of the TOP 100 Swiss Startup Award in 2018 represented by these ventures. In 2019, the initiative aimed to allocate 4.35 million francs to support idea-stage projects, facilitating the transition of Swiss scientific innovations to global markets.
Top Stages
1372 past transactions
JOSEPHA
Grant in 2025
JOSEPHA operates an online platform that simplifies shopping for consumers. It aggregates product information, prices, and offers from various retailers, allowing users to compare options and make informed purchasing decisions quickly and efficiently. The platform also provides detailed product specifications, tutorial videos, and AI-powered search functionality to enhance the user experience.
UNOMR
Grant in 2025
Unomr develops novel nano-micro technology based sensing approaches for diagnostics and drug discovery.
REMUUN
Grant in 2025
REMUUN is a biotechnology company focused on revolutionizing the development of therapeutic antibodies. It has created the MEGA platform, which mimics natural antibody gene modification and employs AID-based gene editing. This technology enables clients to accelerate, reduce costs, and enhance precision in the creation of monoclonal antibody therapies.
Clee Medical
Grant in 2025
Clee Medical specializes in developing innovative neuroimaging and surgical access technologies to improve precision and efficiency in neurosurgery. Their products, which include imaging and sensing systems, provide enhanced access, vision, and navigation within the brain, seamlessly integrating with existing neurosurgical equipment and current surgical routines. This enables healthcare providers to potentially enhance patient outcomes with greater precision.
Carewell
Grant in 2025
Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Verretex
Grant in 2025
Verretex specializes in recycling low-quality glass fiber waste, utilizing proprietary technology to restore its original quality. The company produces high-performance, regenerated glass fiber textiles, serving diverse industries like construction, automotive, and electronics. By transforming waste into reusable materials, Verretex promotes sustainability, reduces carbon emissions, and offers clients eco-friendly, high-quality solutions.
CellX Biosolutions
Pre Seed Round in 2025
CellX Biosolutions specializes in sustainable chemical waste management. It offers services such as custom bacterial community biodiscovery and optimization, biodegradability studies, and deployment using microfluidic devices. The company helps industries treat pollutants like PFAS, pharmaceuticals, and microplastics, and enables chemical and pharmaceutical producers to manage their waste cost-effectively and sustainably.
Dphi Space
Pre Seed Round in 2025
Dphi Space is a pioneering company focused on facilitating affordable access to space for small satellites. They specialize in aggregating multiple satellite payloads onto shared launches, coordinating with launch providers, and managing the entire deployment process. This approach enables researchers to deploy their satellites more quickly and cost-effectively, reducing dependence on dedicated launches and optimizing capacity utilization.
NovoViz
Grant in 2025
NovoViz specializes in the development and production of single-photon computational engines, designed for applications across diverse technological nodes. Their imaging system excels in rapid photon detection and processing, catering to industries seeking high sensitivity, speed, and efficient data management. This technology facilitates real-time data capture and analysis, empowering industries to explore new frontiers, innovate more cost-effectively, and enhance real-world applications.
Mimic
Grant in 2025
Mimic is a company focused on addressing global labor shortages by developing and deploying advanced robotic solutions that integrate smoothly into existing human work environments. Their innovative approach centers on a scalable foundation AI model that facilitates dexterous robotic manipulation through learning from human interactions. Mimic's product offerings include industrial robotic hands designed for gesture-based control and simplified joint mechanics, allowing for cost-effective automation of various tasks. The company's expert team ensures that these grippers are not only efficient but also user-friendly, enhancing productivity in diverse industries.
Scanvio
Grant in 2025
Scanvio offers AI-augmented ultrasound software for faster endometriosis diagnosis, providing expert sonography skills to gynecologists, improving health and surgical education.
Lightium
Seed Round in 2025
Lightium AG is a Swiss startup that specializes in Photonic Integrated Circuits (PIC) foundry and design services utilizing its proprietary Thin-Film Lithium Niobate (TFLN) platform. As Europe’s first production-grade TFLN foundry, Lightium addresses the challenges faced by photonic device manufacturers by providing exceptional photonic performance, a streamlined supply chain, and efficient scaling from prototyping to mass production. The company caters to a diverse range of industries, including telecommunications, data communications, quantum computing, artificial intelligence, and space, enabling the development of advanced photonic solutions. By focusing on high-volume manufacturing and robust process flow, Lightium supports customers in creating the next generation of photonic technologies.
Helix Robotics
Pre Seed Round in 2025
Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics.
qCella
Pre Seed Round in 2025
qCella specializes in innovative heating solutions. It infuses natural fibers with copper to create heating mats that uniformly warm up when connected to a power source, outperforming conventional heating wires. The company's technology extends beyond mats, also heating car seats, interiors, clothing, and other products directly and homogenously, eliminating the need for heat-losing layers.
Actival
Grant in 2024
Actival is a dental technology company that specializes in manufacturing innovative dental aligners. Utilizing patented 3D printing technology, the company incorporates microfluidic channels, antibacterial fluid, fluoride, and customizable flavors into its aligners, aiming to enhance oral hygiene and improve the effectiveness of teeth alignment during orthodontic treatment. Actival is dedicated to precision and oral health, striving to revolutionize orthodontic care through its innovative products.
Jaipur Robotics
Grant in 2024
Jaipur Robotics focuses on developing waste recycling ecosystem doliutions usng AI Algorithms.
Azure Cell Therapies
Grant in 2024
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
BLEEDnFIRE Therapeutics
Grant in 2024
BLEEDnFIRE is a pioneering innovator in siRNA-based therapies for hemophilia. Its mission is to transform patient care and enhance the quality of life through targeted, effective, and novel treatments
California Department of Real Estate
Grant in 2024
California Department of Real Estate focuses on protecting and advancing the public interest in real estate matters. It employs licensing, regulation, education, and enforcement.
Grensol Group
Grant in 2024
Grensol Group mission is to maximize the recycling of end-of-life wastge.
Shape Biopharmaceuticals
Grant in 2024
Shape Biopharmaceuticals is a biotechnology company that specializes in the development of immunotherapeutic drugs aimed at treating chronic diseases with limited treatment options. The company focuses on advanced protein design and formulation technologies to create a new generation of immunotherapies. By addressing unmet medical needs, Shape Biopharmaceuticals seeks to improve patient outcomes for individuals with genetically driven conditions who lack effective therapeutic alternatives. Through its innovative healthcare solutions, the company aims to provide hope and enhance treatment possibilities for patients facing significant health challenges.
Nerai Bio
Seed Round in 2024
Nerai Bio is a biotechnology company that specializes in advancing genetic therapies. It operates an AI-assisted CRISPR protein engineering platform, enabling clients to enhance the development of next-generation therapeutic systems.
Ionic Wind
Grant in 2024
Ionic Wind is a technology company that specializes in energy-efficient airflow solutions. It has developed a patented technology that generates airflow using electric fields instead of traditional rotating machinery, making its systems noiseless and versatile. The company's innovations aim to drive operational efficiency and environmental sustainability across various industries, including drying, electronics cooling, air purification, and extreme condition applications.
CellX Biosolutions
Grant in 2024
CellX Biosolutions specializes in sustainable chemical waste management. It offers services such as custom bacterial community biodiscovery and optimization, biodegradability studies, and deployment using microfluidic devices. The company helps industries treat pollutants like PFAS, pharmaceuticals, and microplastics, and enables chemical and pharmaceutical producers to manage their waste cost-effectively and sustainably.
WasteFlow
Seed Round in 2024
WasteFlow is a technology company that specializes in optimizing recycling processes. It has developed an affordable, user-friendly learning-based vision system to analyze waste flow, identifying waste types and providing valuable insights to enhance recycling efficiency. Unlike existing solutions, WasteFlow aims to offer a comprehensive understanding of recycling processes and their key performance indicators (KPIs) by addressing data gaps throughout the recycling cycle. By empowering all actors in the recycling process with these tools, WasteFlow seeks to increase sorted material purity, maximize existing system performance, and improve recycling energy efficiency.
Sentinus
Seed Round in 2024
Sentinus provides innovative technologies that automate manual assembly operations by incorporating deep-learning-based quality assurance systems.
Optiverse
Grant in 2024
Optiverse is a technology company that specializes in meeting intelligence. It offers a platform that automates various tasks from virtual meetings, including generating automatic meeting minutes, actionable follow-up items, and summaries of video content. The platform uses proprietary video technology and machine learning to streamline workflows and enhance productivity for teams and organizations worldwide.
RTDT Laboratories
Grant in 2024
RTDT is a No-code SaaS for Structural Health Monitoring of wind turbines.
Lighthouse Tech
Grant in 2024
Lighthouse Tech specializes in designing innovative eyewear frames tailored for individuals with vision impairment, blindness, and spatial perceptual disorders. The company has developed smart eyewear that assists users in navigating their environment safely by detecting obstacles above the waist and alerting them through soft haptic vibrations. With a focus on aesthetics, Lighthouse Tech's products maintain the appearance of traditional eyewear and sunglasses, allowing customers to enjoy fashionable options while promoting safe and independent outdoor mobility. This combination of style and functionality enhances users' self-sufficiency and overall well-being.
Translation-X
Pre Seed Round in 2024
Translation-X is a biotechnology company specializing in the development of innovative therapeutics for Autism Spectrum Disorders (ASD). It employs a precision medicine strategy to target core symptoms of ASD, such as social interaction difficulties, aiming to provide effective treatment options for affected individuals.
ValTech Lifesciences
Grant in 2024
ValTech Lifesciences is a medtech startup promoting cardiovascular health through its proprietary heart valve characteristics that improve the performance of mechanical and biological prostheses.
Hoshii
Grant in 2024
Hoshii unifies all B2B wholesaler correspondence into a solitary chat interface driven by artificial intelligence.
Perovskia
Seed Round in 2024
Perovskia specializes in the digital printing of custom solar cells utilizing patent-protected technology. Operating at the convergence of printed electronics, photovoltaics, and material science, the company develops solar cells tailored for diverse electronic devices. Its innovative approach allows for the printing of solar cells directly onto glass and various substrates, presenting significant advantages over conventional silicon-based alternatives. This technology enables electronics manufacturers to enhance battery life and incorporate sustainable power solutions into their products.
Abrinca Genomics
Seed Round in 2024
Abrinca Genomics is a biotechnology company specializing in the development of a web-based platform for managing and analyzing microbial genomics data. The platform is designed to be self-hosted, scalable, and dataset-independent, allowing researchers and bioinformaticians to securely organize, explore, and analyze vast volumes of microbial genome data. It supports multiple annotation formats, offers flexible access controls, and integrates seamlessly into existing workflows.
Deegtal
Grant in 2024
dEEGtal’s use of AI to expedite epilepsy diagnosis could make a significant difference in patient care, by analyzing EEG data quickly, it might help identify patterns or anomalies that could be missed by human reviewers alone.
Flink Robotics
Seed Round in 2024
Flink Robotics is a robotics engineering company that specializes in developing software intelligence robots for material handling. By employing machine learning and computer vision, the company enhances robots with perception capabilities, allowing them to navigate and operate in dynamic environments. Flink's robots are designed to be plug-and-play systems, collaborating seamlessly with one another to generate collision-free motions. This enables clients across diverse industries to streamline their robot implementations, thereby improving operational efficiency.
Amporin Pharmaceuticals
Grant in 2024
Amporin Pharmaceuticals seeks to create a new class of small-molecule medications that block and eradicate harmful soluble oligomers and holes found within cell membranes.
Regenosca
Pre Seed Round in 2024
Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.
TrueYouOmics
Convertible Note in 2024
TrueYouOmics specializes in comprehensive blood testing services, leveraging multi-omics and artificial intelligence to identify disease risks and facilitate preventive health planning. The company's innovative approach involves analyzing an individual's DNA, RNA, and protein data, then integrating these insights with medical knowledge graphs to estimate personalized disease risks. This holistic health assessment empowers individuals to proactively manage their well-being by taking preventive measures.
SurroundPower
Grant in 2024
SurroundPower delivers a new approach with variability, an attractive design, and a higher safety standard than the existing power socket.
DemoSquare
Grant in 2024
DemoSquare is a pioneer in the realm of public-affairs management connect businesses with government affairs by putting regulatory monitoring on autopilot.
8links
Pre Seed Round in 2024
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
8links
Pre Seed Round in 2024
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
MindMetrix
Pre Seed Round in 2024
MindMetrix is a company that specializes in the development of a mental training platform utilizing eye-tracking-based neurofeedback technology. This innovative approach connects neurophysiology with virtual reality, focusing on enhancing mental resilience. By measuring quantifiable physiological parameters, MindMetrix assesses and monitors training improvements over time, allowing athletes to achieve peak performance more efficiently. The company's platform aims to provide effective means of mental training, catering to the needs of individuals seeking to optimize their cognitive capabilities and overall performance.
Isospec Analytics
Pre Seed Round in 2024
Isospec Analytics SA is a life science company specializing in molecular identification. It simplifies the process of identifying molecules, particularly in the fields of glycomics and metabolomics, to facilitate disease biomarker discovery. This, in turn, aids in the development of safer nutritional and pharmaceutical products. The company offers services like biomarker discovery, product characterization, metabolite structural identification, and glycan sequencing, helping clients leverage these complex fields for their research.
Kidemis
Grant in 2024
Kidemis is a company dedicated to developing innovative aquafeed solutions aimed at enhancing the sustainability of the aquaculture industry. It focuses on producing mycoprotein, a sustainable alternative to fishmeal and fish oil, sourced from renewable resources. By utilizing mycelium-based fermentation, Kidemis converts industrial food waste into low-processed protein ingredients, addressing both food waste and the global undersupply of nutrition. This approach not only reduces the environmental impact of aquaculture but also provides clients with eco-friendly and cost-effective alternatives to traditional protein sources, suitable for use in various meat replacement and vegan nutrition products.
Dphi Space
Pre Seed Round in 2024
Dphi Space is a pioneering company focused on facilitating affordable access to space for small satellites. They specialize in aggregating multiple satellite payloads onto shared launches, coordinating with launch providers, and managing the entire deployment process. This approach enables researchers to deploy their satellites more quickly and cost-effectively, reducing dependence on dedicated launches and optimizing capacity utilization.
Pace Locator
Grant in 2024
Pace Locator is a medical technology company that specializes in developing advanced imaging software. Its flagship product, also named Pace Locator, uses electrocardiogram (ECG) and echocardiogram (ECHO) data to generate 3D maps of the heart. This innovative tool helps healthcare professionals localize the source of cardiac arrhythmias and visualize the location of cardiac implantable electronic device (CIED) leads, enabling faster and more accurate diagnoses.
NovoViz
Grant in 2024
NovoViz specializes in the development and production of single-photon computational engines, designed for applications across diverse technological nodes. Their imaging system excels in rapid photon detection and processing, catering to industries seeking high sensitivity, speed, and efficient data management. This technology facilitates real-time data capture and analysis, empowering industries to explore new frontiers, innovate more cost-effectively, and enhance real-world applications.
Procavea Biotech
Grant in 2023
Procavea Biotech specializes in developing a drug delivery platform utilizing non-viral protein cages. This innovative technology is tailored specifically for veterinary professionals, aiming to streamline and improve the efficiency of veterinary practice management. By providing a comprehensive solution, Procavea Biotech enhances the overall effectiveness of veterinary services, allowing practitioners to integrate processes seamlessly and elevate the quality of care offered to their clients.
AskEarth
Grant in 2023
AskEarth is a Swiss-based startup founded by researchers from the University of Zurich (UZH), ETH Zurich, and EPFL. It operates a geospatial intelligence platform that processes real-time satellite imagery to provide accurate, up-to-date information about Earth's surface changes. The company specializes in monitoring deforestation, coastline progressions, glacier melting, and transportation infrastructure, with a focus on supporting the European Union's Deforestation Regulation (EUDR). AskEarth offers an easy-to-use tool for clients to access unique earth observation data, enabling them to validate news articles and gain insights into planetary changes with just one click.
Planeto
Grant in 2023
Planeto is an energy transition company specializing in energy planning software solutions. It focuses on developing energy efficiency software aimed at decarbonizing the heating energy supply in buildings. The company's offerings include district heating and cooling networks that facilitate the connection of buildings to renewable energy sources, thereby enabling clients to achieve a sustainable and clean environment.
RefFIT
Grant in 2023
RefFIT provides software for spectroscopic data analysis in material science, allowing users to use the tool without requiring expert training. This saves time and money in data analysis and model development for the company's growing user base.
Orio Therapeutics
Convertible Note in 2023
Orio Therapeutics specializes in regenerative medicine and protein engineering. The company modifies therapeutic proteins to enhance their delivery and efficacy, focusing on controlled localization. This approach aims to improve patient outcomes, particularly for those with myocardial infarction, while potentially reducing dosage requirements.
Chiral
Grant in 2023
Chiral is a manufacturer specializing in next-generation electronics utilizing advanced nanomaterials. The company focuses on producing nanomaterial-based transistors, particularly those made from carbon nanotubes, which are designed for the automated assembly of clean nanomaterials at the wafer scale. Chiral's innovative approach enables clients to develop and implement computing and quantum technologies, facilitating the transition from research to commercial applications at an industrial scale. By leveraging cutting-edge nanotechnology, the company aims to meet the growing demands of the electronics market.
Ascento
Grant in 2023
Ascento Robotics focuses on developing wheeled bipedal robotic systems designed for practical applications in outdoor security. By integrating the agility of legs with the efficiency of wheels, the company's robots can navigate obstacles such as stairs while providing quick and energy-efficient movement. Their robotics-as-a-service platform enhances outdoor security patrolling, allowing professionals to secure and inspect assets more effectively. This innovative approach not only reduces intervention times but also improves data collection capabilities, making it suitable for various real-world scenarios.
HeroSupport
Grant in 2023
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.
Tethys Robotics
Grant in 2023
Tethys Robotics specializes in the development of AI-powered robotics systems designed for underwater applications. The company's technology focuses on creating modular, omnidirectional robots capable of performing a variety of tasks in challenging aquatic environments. Their products are engineered to enhance underwater search and recovery operations, inspections, mapping, and exploration. By enabling professionals to collect and process data effectively, Tethys Robotics aims to ensure that these tasks can be carried out safely, reliably, and efficiently, addressing the unique challenges posed by underwater environments.
qCella
Grant in 2023
qCella specializes in innovative heating solutions. It infuses natural fibers with copper to create heating mats that uniformly warm up when connected to a power source, outperforming conventional heating wires. The company's technology extends beyond mats, also heating car seats, interiors, clothing, and other products directly and homogenously, eliminating the need for heat-losing layers.
csky.ai
Pre Seed Round in 2023
csky.ai is a technology company focused on enhancing the security and confidentiality of sensitive conversations through its innovative Edge AI solutions. The company develops advanced microphones that process and enhance confidential discussions while preserving privacy. By utilizing edge artificial intelligence, csky.ai ensures that data is processed locally on the device, eliminating the necessity for cloud storage. This approach allows organizations to generate secure, structured, and compliant transcripts of confidential meetings, transforming sensitive conversations into organized documents without compromising data security.
Orio Therapeutics
Convertible Note in 2023
Orio Therapeutics specializes in regenerative medicine and protein engineering. The company modifies therapeutic proteins to enhance their delivery and efficacy, focusing on controlled localization. This approach aims to improve patient outcomes, particularly for those with myocardial infarction, while potentially reducing dosage requirements.
Inverto
Grant in 2023
Inverto's goal is to automate mangrove restoration as a service for mangrove restoration organizations. Mangroves are much better carbon sinks than terrestrial forests and are essential for biodiversity.
TALPA Inspection
Grant in 2023
TALPA Inspection provides electrochemical techniques for detecting corrosion damage in reinforced concrete subsurfaces.
Transpire Bio
Grant in 2023
Transpire Bio is a biotechnology platform focused on the development of inhaled therapeutics aimed at improving healthcare outcomes globally. The company specializes in the commercialization of lower-cost generic alternatives for injectable drugs, utilizing innovative delivery methods to enhance patient experience by providing painless administration. Transpire Bio's product portfolio includes medicines and inhalation therapies targeting both lung diseases and systemic conditions, reflecting its commitment to addressing a wide range of health challenges through advanced biopharmaceutical solutions.
Cotierra
Grant in 2023
Cotierra operates a decentralized biochar production platform, Terra Preta, which aims to remove carbon from the atmosphere and enhance soil health. The company transforms farmers' agricultural residues into a natural soil enhancer, biochar, using a mobile, cost-effective reactor. This process is digitally tracked and verified, enabling companies to offset their emissions and improve climate resilience in agricultural supply chains while benefiting farmers' livelihoods.
plasNifix
Grant in 2023
PlasNifix is a technology company that has developed a novel process for nitrogen fixation, using plasma assistance to enable the production of ammonia and other nitrogen-containing compounds at lower temperatures and with significantly less energy. This innovative method relies on proprietary catalysts and plasma generators, facilitating a more efficient and sustainable production process that can help agricultural and fertilizer industries reduce their dependence on fossil fuels.
AlpineWell
Grant in 2023
AlpineWell developing novel solutions to hunger and swallowing difficulties, AlpineWell produces patient-centric food for special medicinal purposes (FSMP) and also provides automatic nutrition tracking to detect malnutrition early on.
Gaia Tech
Pre Seed Round in 2023
Gaia Technologies specializes in transforming agricultural byproducts into valuable ingredients through an innovative and scalable extraction process. The company focuses primarily on olive waste, utilizing its technology to convert these sidestreams into bio-compounds such as antioxidants, biochar, activated carbon, and biogas. By addressing the growing demand for natural alternatives to synthetic compounds in the cosmetics, food, and feed industries, Gaia Technologies not only creates new value streams for primary sector firms but also contributes to reducing their environmental impact. The company's approach is designed to support a circular economy within the food production sector by enabling the substitution of synthetic and fossil-based ingredients with those derived from agricultural waste.
CompagOs
Convertible Note in 2023
CompagOs is a company dedicated to improving cancer treatment outcomes by providing personalized solutions for patients with bone cancer. The company utilizes 3D bioprinting technology to recreate the unique cancerous conditions of a patient's bone in a controlled laboratory environment, allowing oncologists to assess different drug reactions and determine the most effective treatment options. By using mineralized three-dimensional bio-printed bone organoids, CompagOs surpasses the limitations of conventional animal and 2D models, offering a more accurate representation of human physiological conditions. This technology not only aids in personalized patient care but also serves as a powerful tool for drug development, enabling researchers to evaluate drug efficacy in a realistic and patient-relevant setting.
Isospec Analytics
Grant in 2023
Isospec Analytics SA is a life science company specializing in molecular identification. It simplifies the process of identifying molecules, particularly in the fields of glycomics and metabolomics, to facilitate disease biomarker discovery. This, in turn, aids in the development of safer nutritional and pharmaceutical products. The company offers services like biomarker discovery, product characterization, metabolite structural identification, and glycan sequencing, helping clients leverage these complex fields for their research.
CERN
Grant in 2023
CERN is a prominent particle-physics laboratory located in Geneva, Switzerland, established in 1954. It serves as the European organization for nuclear research, where physicists and engineers investigate the fundamental structure of the universe. CERN specializes in providing advanced particle accelerators and detectors, which are essential for high-energy physics research. These accelerators propel beams of particles to high energies, enabling collisions that are then analyzed by sophisticated detectors to explore the basic constituents of matter and the forces between them. Governed by 22 member states, CERN represents a significant collaborative effort in scientific research, focusing on the fundamental questions of physics and contributing to the global understanding of the universe.
a-metal
Grant in 2023
A-metal is a manufacturer specializing in three-dimensional (3D) printers that focus on making metal additive manufacturing accessible to a wide range of organizations. The company offers an affordable, compact, and safe laser powder bed fusion (LPBF) machine, which features a unique cartridge system for safe powder handling. This innovative design enables the operation of the printer without the need for a laboratory environment, making it particularly beneficial for small and medium enterprises (SMEs) and small research and development departments. A-metal's technology allows these entities to produce small quantities of metal parts for prototypes, testing, or limited production runs, thus enhancing their capacity for innovation and sustainability in the manufacturing sector.
Apheros
Grant in 2023
Apheros is a company specializing in metal foam cooling solutions, focusing on innovative applications in cooling and catalysis. It utilizes a patent-pending manufacturing approach that allows for the scalable production of metal foams with distinct cooling properties. The company produces a diverse range of metal foams, including iron, stainless steel, copper, and nickel, while preserving their thermal and electrical conductivity as well as mechanical stability. This unique combination of attributes enables clients to develop advanced products for various applications, including cooling systems, lubrication, and catalysis in battery materials.
irmos
Grant in 2023
Irmos Technologies is a start-up focused on transforming the repair and preservation of bridges and buildings through real-time, AI-powered structural condition evaluation. The company has developed a data-driven platform for structural health monitoring, which provides engineers with advanced tools to assess the condition of real structures. This innovative software solution enables clients to monitor structural health effectively, thereby reducing maintenance costs, extending the lifespan of assets, and enhancing public safety. By leveraging cutting-edge technology, Irmos Technologies aims to maximize the safe operational life of existing infrastructure.
Neology Hydrogen
Convertible Note in 2023
Neology’s ammonia-powered genset represents the next generation of clean power solutions. This advanced system delivers reliable energy with zero emissions, operating completely carbon-free. Designed to be mobile and versatile, it is perfect for off-grid and remote applications. Additionally, its silent operation ensures minimal noise pollution, making it an ideal choice for sustainable and efficient energy generation in any environment.
ASTRA Therapeutics
Grant in 2023
ASTRA Therapeutics is a medication development company focused on creating innovative therapies for parasitic diseases. Utilizing advanced science and technology, the company develops precision-engineered drugs to combat a wide range of parasitic disorders, including malaria, cryptosporidiosis, and toxoplasmosis. Its mission is to address the global health burden posed by these conditions by bringing effective treatment candidates to market.
Vamoz
Convertible Note in 2023
Vamoz is a Swiss-based SaaS solution enabling companies to make remote work abroad an official benefit for their employees. Whether that means to work from the beach in Mexico or from a relative's house by the sea. Our vision is to inspire and facilitate those reimagining traditional work-life. Giving employees the opportunity to work temporarily from anywhere, and companies the chance to attract and retain top talent without facing uncontrollable legal and business risks. Vamoz!
metaLead Therapeutics
Grant in 2023
metaLead Therapeutics is a biopharmaceutical company focused on developing innovative peptide medications to address metal-related diseases, particularly lead poisoning. The company’s research centers on creating a next-generation treatment that specifically targets and binds lead ions while safeguarding essential metal ions in the body. This targeted approach results in a highly stable medication that can be administered both orally and intravenously. By providing an effective detoxification solution, metaLead Therapeutics aims to improve the health outcomes of individuals affected by lead poisoning on a global scale.
Tandem Therapeutics
Grant in 2023
Tandem Therapeutics is a biopharmaceutical company dedicated to pioneering treatments for fibrotic diseases. It focuses on the extracellular matrix, a complex network of proteins that surrounds cells, and develops peptide therapeutics, known as Matrix Targeting Peptides (MTPs), to target and treat the extracellular matrix barrier. This innovative approach aims to provide more precise and effective treatments for patients suffering from fibrotic conditions, including cancers and organ fibrosis.
Adularia
Grant in 2023
Adularia is a microbial-based therapy for Colorectal cancer.
Rapidata
Convertible Note in 2023
Rapidata is a data processing platform that specializes in providing human-verified data labeling and processing services. The company has developed technology that facilitates the efficient handling of large datasets, leveraging human intelligence to ensure accuracy and relevance. Its platform allows customers to customize their data labeling tasks according to specific needs, enhancing scalability and cost-effectiveness. By focusing on innovative solutions, Rapidata enables clients to access reliable data labeling and validation services tailored to their requirements.
Correntics
Pre Seed Round in 2023
Correntics is a company focused on enhancing the resilience of global supply chains through a climate risk assessment platform. By employing a data-driven approach, it provides clients with comprehensive insights into their supply chains, covering aspects from raw material availability to final delivery. The platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling businesses to identify and mitigate potential disruptions. Correntics aims to improve operational efficiency and financial stability for its clients while addressing the challenges posed by climate change and emerging risks, ultimately supporting the sustainability of their business activities.
Optiml
Grant in 2022
Optiml is a company that specializes in real estate investment and renovation planning through its innovative software solution. The platform is designed to empower real estate professionals by providing AI-driven tools for optimizing building operations and minimizing environmental impact. By analyzing data on energy consumption, occupancy patterns, and weather conditions, Optiml identifies areas for improvement and automates adjustments to systems such as heating, ventilation, and lighting. This enables users to achieve sustainability goals while maintaining profitability. The software addresses common challenges in the real estate sector, such as inadequate data, manual workflows, and evolving regulatory contexts, by offering scalable solutions that enhance asset and portfolio management. Through its cutting-edge SaaS approach, Optiml supports real estate professionals in understanding their current status, optimizing investment strategies, planning renovation actions, and ensuring long-term compliance with sustainability standards.
Rhovica Neuroimaging
Grant in 2022
Rhovica Neuroimaging is a rapid and safe placement of an external ventricular drain (EVD) and is a lifesaving emergency procedure. EVDs are thin catheters, that are inserted into the brain cavities (ventricles) for fluid drainage to decrease intracranial pressure (ICP) and for measurement of ICP.
Evoly
Grant in 2022
Evoly specializes in transforming traditional energy and water meters into smart devices, significantly reducing costs for energy providers. The company develops technology that facilitates the collection and analysis of consumption data, offering a comprehensive software-as-a-service solution. This includes a combination of hardware and software that allows for plug-and-play meter installations. Evoly's offerings provide real-time insights into the electric grid, gateway management services, and live data tracking. By automating essential tasks, the technology enables energy providers to detect fraud, perform remote readings, implement automatic billing, and adjust pricing dynamically, ultimately enhancing operational efficiency and customer engagement.
Simon & Joseph
Grant in 2022
Simon & Josef specializes in providing a personalized room service system for the hospitality industry, enabling hotels to enhance guest experiences while promoting environmental sustainability. Their innovative solution allows guests who stay two nights or more to customize their room cleaning preferences, ensuring that resources such as water, electricity, and cleaning products are used efficiently. By allowing guests to request services only when necessary, the company helps hotels reduce operational costs and minimize their environmental impact. This approach not only caters to the individual needs of guests but also supports hoteliers in their efforts to operate in a more sustainable manner.
WattAnyWhere
Grant in 2022
WattAnyWhere is a company focused on revolutionizing the delivery of high power electricity through innovative, decentralized solutions that prioritize renewable energy. It develops clean electricity generators specifically designed to provide fast-charging services for battery electric vehicles. By utilizing renewable ethanol derived from biomass, WattAnyWhere's mobile generators convert this energy source into clean electricity. This approach not only facilitates high-power generation in remote locations but also supports environmental sustainability by reducing greenhouse gas emissions. The company aims to enhance accessibility to electric vehicle charging while promoting a shift away from fossil fuels toward cleaner energy alternatives.
Ocumeda
Grant in 2022
Ocumeda is a telemedical network specializing in ophthalmology, providing accessible eye screening services through collaborations with opticians, retirement homes, and companies. The company employs board-certified ophthalmologists who conduct medical assessments remotely, utilizing a secure cloud platform. Additionally, Ocumeda integrates medical artificial intelligence products to enhance the screening process, enabling opticians and pharmacies to detect conditions that may lead to blindness and vision loss. By lowering barriers to eye examinations, Ocumeda aims to improve overall eye health and accessibility to care.
Splint Invest
Grant in 2022
Splint Invest is a financial services company that operates a marketplace for retail investors seeking access to alternative investments. The company provides a platform where pre-selected issuers can offer their investment products, allowing private investors to engage in fractional investments. Utilizing advanced technologies, such as distributed ledger technology and artificial intelligence, Splint Invest streamlines the investment process by handling legal requirements, tokenization, custody, data management, and cash management. This innovative approach enables investors to diversify their portfolios and access a range of previously unserved investment opportunities.
Aukera Therapeutics
Grant in 2022
Aukera Therapeutics is a biotechnology company focused on creating innovative therapeutics for patients afflicted by diseases related to the mTOR protein, including cancer and neurodegenerative disorders. Originating as a spin-off from the Biozentrum of the University of Basel, the company has developed a pharmaceutical drug discovery engine aimed at producing selective inhibitors of the mTOR complex. This technology enables the development of drugs that specifically target various branches of the mTOR signaling pathway, which plays a crucial role in regulating cell growth. By providing targeted treatments, Aukera Therapeutics seeks to improve patient outcomes in the management of mTOR-related diseases.
Correntics
Grant in 2022
Correntics is a company focused on enhancing the resilience of global supply chains through a climate risk assessment platform. By employing a data-driven approach, it provides clients with comprehensive insights into their supply chains, covering aspects from raw material availability to final delivery. The platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling businesses to identify and mitigate potential disruptions. Correntics aims to improve operational efficiency and financial stability for its clients while addressing the challenges posed by climate change and emerging risks, ultimately supporting the sustainability of their business activities.
Rapidata
Convertible Note in 2022
Rapidata is a data processing platform that specializes in providing human-verified data labeling and processing services. The company has developed technology that facilitates the efficient handling of large datasets, leveraging human intelligence to ensure accuracy and relevance. Its platform allows customers to customize their data labeling tasks according to specific needs, enhancing scalability and cost-effectiveness. By focusing on innovative solutions, Rapidata enables clients to access reliable data labeling and validation services tailored to their requirements.
Vamoz
Convertible Note in 2022
Vamoz is a Swiss-based SaaS solution enabling companies to make remote work abroad an official benefit for their employees. Whether that means to work from the beach in Mexico or from a relative's house by the sea. Our vision is to inspire and facilitate those reimagining traditional work-life. Giving employees the opportunity to work temporarily from anywhere, and companies the chance to attract and retain top talent without facing uncontrollable legal and business risks. Vamoz!
matriq
Seed Round in 2022
matriq AG is a machinery manufacturing company based in St. Gallenkappel, Switzerland, specializing in innovative marking solutions for plastic components. Founded in 2019, the company has developed patented DynamicMold technology that allows for the individual marking of plastic parts directly during the manufacturing process, including methods such as injection molding, blow molding, and thermoforming. This technology enables each plastic item to bear a unique and tamper-proof code, enhancing traceability and product protection for manufacturers. By integrating marking capabilities into the production line, matriq AG provides solutions that support brand integrity and consumer trust.
Biosimo Chemicals
Pre Seed Round in 2022
Biosimo Chemicals is a chemical engineering start-up focused on the development and operation of processes to produce bio-based platform chemicals. The company aims to create sustainable chemical solutions through innovative catalytic reactions and purification processes. Its flagship technology offers a novel method for producing acetic acid, replacing traditional methods that rely on coal and gas with a process that utilizes ethanol derived from biomass and waste. This advancement provides the chemical, pharmaceutical, and materials industries with a direct alternative to fossil-based resources, aligning with global sustainability goals.
Sensawear
Grant in 2022
Sensawear is a medical technology company that specializes in the production of wearable, textile-integrated sensors. These sensors monitor tissue oxygenation and skin pressure in real-time, alerting users to potential pressure injuries before they occur. By providing early warnings of low-oxygenation conditions caused by high-pressure points, Sensawear's products enable users to take preventative action, such as moving or being moved, thus minimizing the risk of painful and dangerous pressure ulcers.
SightIn Health
Grant in 2022
SightIn Health is a company that specializes in the development of artificial intelligence-powered software designed for portable ultrasound applications. Founded in 2021 and based in Geneva, Switzerland, the company focuses on enhancing the capabilities of ultrasound machines by providing advanced image analytics, usage guidance, and interpretation of patient diagnostics. Its platform automates quality assessment and ultrasound probe guidance, effectively lowering the skill barrier required for healthcare professionals to operate ultrasound equipment. By streamlining the process of capturing and interpreting medical imaging, SightIn Health aims to improve the accuracy of medical diagnostics and prognostics in healthcare settings.
Synature
Grant in 2022
Synature AG, a Swiss startup based at EPFL Innovation Park, specializes in biodiversity monitoring. It uses bioacoustics, recording and analyzing natural sounds, to quantify ecosystem health. The company offers automated, autonomous recorders that transmit audio data, AI-driven analysis, and a user-friendly dashboard for data visualization.
Maven Health
Non Equity Assistance in 2022
Maven Health is a health technology company that provides an innovative metabolic health solution aimed at healthcare providers. The company employs saliva as the bio-fluid for analyzing metabolites through advanced Nuclear Magnetic Resonance (NMR) spectrometry, utilizing proprietary analytical methods. This approach allows for a comprehensive assessment of individuals' metabolic health with minimal invasiveness and at a competitive cost. By delivering results via an intuitive data platform, Maven Health enables healthcare professionals to effectively identify individuals at risk for metabolic disorders who may not be detected through conventional healthcare practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.